Register entry

Sinopep-Allsino Biopharmaceutical Co., Ltd.

Registered sites
1
Drug products
13
Live patents
0
Countries
1
Base
China
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackaging
Sites

Facilities

1
SiteLocationOperationsFEI
Sinopep-Allsino Biopharmaceutical Co., Ltd.LianyungangChinaAnalytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging3005460102
Catalogue

Marketed products

13

Showing 13 of 13.

BrandGeneric nameFormCategory
-BivalirudinPOWDERBULK INGREDIENT
-BivalirudinPOWDERBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-FulvestrantPOWDERBULK INGREDIENT
-LiraglutidePOWDERBULK INGREDIENT
-LiraglutidePOWDERBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-SemaglutidePOWDERBULK INGREDIENT
-SemaglutidePOWDERBULK INGREDIENT
-SemaglutidePOWDERBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-TirzepatidePOWDERBULK INGREDIENT
-TirzepatidePOWDERBULK INGREDIENT
-decoquinatePOWDERBULK INGREDIENT
-dinitolmidePOWDERBULK INGREDIENT
-octreotide acetatePOWDERBULK INGREDIENT
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.